|
1
|
Asna N, Livoff A, Batash R, Debbi R,
Schaffer P, Rivkind T and Schaffer M: Radiation therapy and
immunotherapy-a potential combination in cancer treatment. Curr
Oncol. 25:e454–e460. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pajamäki N, Metso S, Hakala T, Ebeling T,
Huhtala H, Ryödi E, Sand J, Jukkola-Vuorinen A, Kellokumpu-Lehtinen
PL and Jaatinen P: Long-term cardiovascular morbidity and mortality
in patients treated for differentiated thyroid cancer. Clin
Endocrinol (Oxf). 88:303–310. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Topstad D and Dickinson JA: Thyroid cancer
incidence in Canada: A national cancer registry analysis. CMAJ
Open. 5:E612–E616. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hazama S, Tamada K, Yamaguchi Y, Kawakami
Y and Nagano H: Current status of immunotherapy against
gastrointestinal cancers and its biomarkers: Perspective for
precision immunotherapy. Ann Gastroenterol Surg. 2:289–303. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao Y, Liu Y, Ma X, Wei L, Chen W and Song
L: The incidence and risk factors of peripherally inserted central
catheter-related infection among cancer patients. Ther Clin Risk
Manag. 11:863–871. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Osmani L, Askin F, Gabrielson E and Li QK:
Current WHO guidelines and the critical role of immunohistochemical
markers in the subclassification of non-small cell lung carcinoma
(NSCLC): Moving from targeted therapy to immunotherapy. Semin
Cancer Biol. 52:103–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng F, Liang H, Butte AJ, Eng C and
Nussinov R: Personal mutanomes meet modern oncology drug discovery
and precision health. Pharmacol Rev. 71:1–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johansson E, Hammarskjöld F, Lundberg D
and Arnlind MH: Advantages and disadvantages of peripherally
inserted central venous catheters (PICC) compared to other central
venous lines: A systematic review of the literature. Acta Oncol.
52:886–892. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cooper DS, Doherty GM, Haugen BR, Kloos
RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F,
Schlumberger M, et al American Thyroid Association (ATA) Guidelines
Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, :
Revised American Thyroid Association management guidelines for
patients with thyroid nodules and differentiated thyroid cancer:
The American Thyroid Association (ATA) guidelines taskforce on
thyroid nodules and differentiated thyroid cancer. Thyroid.
19:1167–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Loveday HP, Wilson JA, Pratt RJ, Golsorkhi
M, Tingle A, Bak A, Browne J, Prieto J and Wilcox M; UK Department
of Health, : epic3: National evidence-based guidelines for
preventing healthcare-associated infections in NHS hospitals in
England. J Hosp Infect. 86 (Suppl 1):S1–S70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taylor JE, McDonald SJ and Tan K:
Prevention of central venous catheter-related infection in the
neonatal unit: A literature review. J Matern Fetal Neonatal Med.
28:1224–1230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Davis MH: Pediatric central venous
catheter management: A review of current practice. JAVA. 18:93–98.
2013. View Article : Google Scholar
|
|
14
|
McMullan C, Propper G, Schuhmacher C,
Sokoloff L, Harris D, Murphy P and Greene WH: A multidisciplinary
approach to reduce central line-associated bloodstream infections.
Jt Comm J Qual Patient Saf. 39:61–69. 2013.PubMed/NCBI
|
|
15
|
Broadhurst D, Moureau N and Ullman AJ;
World Congress of Vascular Access (WoCoVA) Skin Impairment
Management Advisory Panel, : Management of central venous access
device-associated skin impairment: An evidence-based algorithm. J
Wound Ostomy Continence Nurs. 44:211–220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schiffer CA, Mangu PB, Wade JC,
Camp-Sorrell D, Cope DG, El-Rayes BF, Gorman M, Ligibel J,
Mansfield P and Levine M: Central venous catheter care for the
patient with cancer: American Society of Clinical Oncology clinical
practice guideline. J Clin Oncol. 31:1357–1370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cotogni P and Pittiruti M: Focus on
peripherally inserted central catheters in critically ill patients.
World J Crit Care Med. 3:80–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chopra V, Flanders SA, Saint S, Woller SC,
O'Grady NP, Safdar N, Trerotola SO, Saran R, Moureau N, Wiseman S,
et al Michigan Appropriateness Guide for Intravenouse Catheters
(MAGIC) Panel, : The Michigan Appropriateness Guide for Intravenous
Catheters (MAGIC): Results from a multispecialty panel using the
RAND/UCLA appropriateness method. Ann Intern Med. 163 (Suppl
6):S1–S40. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Walz JM, Memtsoudis SG and Heard SO:
Prevention of central venous catheter bloodstream infections. J
Intensive Care Med. 25:131–138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pinelli F, Cecero E, Degl'Innocenti D,
Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S and Pittiruti M:
Infection of totally implantable venous access devices: A review of
the literature. J Vasc Access. 19:230–242. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shang M, Chang C, Pei Y, Guan Y, Chang J
and Li H: Potential management of circulating tumor DNA as a
biomarker in triple-negative breast cancer. J Cancer. 9:4627–4634.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hatakeyama N, Hori T, Yamamoto M, Mizue N,
Inazawa N, Igarashi K, Tsutsumi H and Suzuki N: An evaluation of
peripherally inserted central venous catheters for children with
cancer requiring long-term venous access. Int J Hematol.
94:372–377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Macmillan T, Pennington M, Summers JA,
Goddard K, Zala D, Herz N, Peacock JL, Keevil S and Chalkidou A:
SecurAcath for securing peripherally inserted central catheters: A
NICE medical technology guidance. Appl Health Econ Health Policy.
16:779–791. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ignatov A, Hoffman O, Smith B, Fahlke J,
Peters B, Bischoff J and Costa SD: An 11-year retrospective study
of totally implanted central venous access ports: Complications and
patient satisfaction. Eur J Surg Oncol. 35:241–246. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Subramaniam A, Kim KH, Bryant SA, Kimball
KJ, Huh WK, Straughn JM, Estes JM and Alvarez RD: Incidence of
mechanical malfunction in low-profile subcutaneous implantable
venous access devices in patients receiving chemotherapy for
gynecologic malignancies. Gynecol Oncol. 123:54–57. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ahn SJ, Kim HC, Chung JW, An SB, Yin YH,
Jae HJ and Park JH: Ultrasound and fluoroscopy-guided placement of
central venous ports via internal jugular vein: Retrospective
analysis of 1254 port implantations at a single center. Korean J
Radiol. 13:314–323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Covey AM, Toro-Pape FW, Thornton RH, Son
C, Erinjeri J, Sofocleous CT, Brody LA, Brown KT, Sepkowitz KA and
Getrajdman GI: Totally implantable venous access device placement
by interventional radiologists: Are prophylactic antibiotics
necessary? J Vasc Interv Radiol. 23:358–362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taxbro K, Hammarskjöld F, Thelin B, Lewin
F, Hagman H, Hanberger H and Berg S: Clinical impact of
peripherally inserted central catheters vs implanted port catheters
in patients with cancer: An open-label, randomised, two-centre
trial. Br J Anaesth. 122:734–741. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Biacchi D, Sammartino P, Sibio S, Accarpio
F, Cardi M, Sapienza P, De Cesare A, Atta JM, Impagnatiello A and
Di Giorgio A: Does the implantation technique for totally
implantable venous access ports (TIVAPs) influence long-term
outcome? World J Surg. 40:284–290. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Patel GS, Jain K, Kumar R, Strickland AH,
Pellegrini L, Slavotinek J, Eaton M, McLeay W, Price T, Ly M, et
al: Comparison of peripherally inserted central venous catheters
(PICC) versus subcutaneously implanted port-chamber catheters by
complication and cost for patients receiving chemotherapy for
non-haematological malignancies. Support Care Cancer. 22:121–128.
2014. View Article : Google Scholar : PubMed/NCBIPubMed/NCBIPubMed/NCBI
|
